{1 (100 ML omidubicel-onlv 8000000 CELLS/ML Injection) / 1 (50 ML omidubicel-onlv 8000000... — RxCUI 2637364
RxNorm drug concept · Brand name pack
RxCUI 2637364
Brand name pack · BPCK
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2637364
Official name{1 (100 ML omidubicel-onlv 8000000 CELLS/ML Injection) / 1 (50 ML omidubicel-onlv 8000000 CELLS/ML Injection) } Pack [Omisirge]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asOmisirge Cultured and Non-Cultured Injection Pack
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How {1 (100 ML omidubicel-onlv 8000000 CELLS/ML Inje... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{1 (100 ML omidubicel-onlv 8000000 CELLS/ML Injection) / 1 (50 ML omidubicel-onlv 8000000 CELLS/ML Injection) } Pack [Omisirge]
RxCUI 2637364 Brand name pack · BPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Omidubicel
2637355IN -
Omidubicel-onlv
2637354PIN
-
Omidubicel
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Omidubicel Injection
2637359SCDF -
Omidubicel-onlv Injection
2648320SCDFP -
Omidubicel Injectable Product
2637358SCDG -
Omidubicel-onlv Injectable Product
2661557SCDGP -
Pack
746839DF -
Injectable Product
1151126DFG
-
Omidubicel Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
100 ML omidubicel-onlv 8000000 CELLS/ML Injection
2637360SCD -
50 ML omidubicel-onlv 8000000 CELLS/ML Injection
2637362SCD -
Omidubicel-onlv 8000000 CELLS/ML
2637357SCDC
-
100 ML omidubicel-onlv 8000000 CELLS/ML Injection
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
100 ML omidubicel-onlv 8000000 CELLS/ML Injection
SCD · 2637360 -
50 ML omidubicel-onlv 8000000 CELLS/ML Injection
SCD · 2637362 -
{1 (100 ML omidubicel-onlv 8000000 CELLS/ML Injection) / 1 (50 ML omidubicel-onlv 8000000 CELLS/ML Injection) } Pack
GPCK · 2637363 -
Omidubicel-onlv 8000000 CELLS/ML
SCDC · 2637357 -
Omidubicel Injection
SCDF · 2637359 -
Omidubicel-onlv Injection
SCDFP · 2648320 -
Omidubicel Injectable Product
SCDG · 2637358 -
Omidubicel-onlv Injectable Product
SCDGP · 2661557
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2637364 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 73441-0800-04 | 1 KIT in 1 KIT (73441-800-04) * 10 mL in 1 BAG (73441-200-... | OMISIRGE | Gamida Cell Inc. | 2023-05-01 |
Observed labelers:
Gamida Cell Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.